Articles
NUS Aquaculture Oral Vaccine for Nervous Necrosis Virus 2026
NUS researchers developed an oral vaccine approach that protected farmed fish against nervous necrosis virus, a major aquaculture disease threat.
NUS Aquaculture Oral Vaccine for Nervous Necrosis Virus 2026
Disease and research result
NUS researchers reported on 29 June 2026 an oral-vaccine approach that protected farmed fish against nervous necrosis virus (NNV), a disease that can cause major losses in aquaculture. The work addresses disease management in fish farming and is research evidence, not a declaration that NNV has been eliminated from Singapore farms. (NUS, 29 June 2026, accessed 5 September 2026.)
Aquaculture and food-security relevance
NUS positioned the work as a potential tool for improving disease resilience and supporting sustainable aquaculture. An oral delivery method could make vaccination easier to administer at farm scale than individually handling fish, but the announcement does not establish regulatory approval, commercial availability, universal protection across species or a defined deployment date. (NUS, 29 June 2026, accessed 5 September 2026.)
Evidence boundary
The reported finding is a research breakthrough by NUS and should be read alongside later study details, validation and regulatory assessments. It does not by itself change Singapore aquaculture licensing, food-safety rules or vaccination requirements, and it is not a human vaccine or clinical-health intervention. (NUS, 29 June 2026, accessed 5 September 2026.)
Record details
- Also known as
- ["NUS nervous necrosis virus vaccine","NNV oral vaccine Singapore","aquaculture oral vaccine"]
- Jurisdiction
- SG
Dates describe this record’s own period and applicability. A verification date does not mean a rule is currently in force.
Sources
Collection as of 2026-10-07 · An expanding collection. Published counts show available knowledge, not complete coverage of Singapore.